Exciting to see our technology enabling groundbreaking environmental research! 🌊 At Acytronix, we’re proud to support Dr. Ksenia Groh and her team (with Romain Héraud) at Eawag (Swiss Federal Institute of Aquatic Science and Technology), who are using our device to isolate environmental extracellular vesicles (EVs), vesicles released by living organisms into the aquatic environment. Thanks to the capabilities of our device, we can efficiently separate these environmental EVs by processing extremely large volumes of liquid without any need for filtration or additional processing steps. The device is highly stable and selective, enabling reliable capture of biological particles even from challenging environments such as aquariums and high-volume natural water sources, under a wide range of conditions. Our technology opens the door to diverse and integrative research, exactly as demonstrated in the work of Dr. Ksenia Groh and her team. We’re happy to support to the next generation of environmental monitoring and EV biology! #EnvironmentalMonitoring #ExtracellularVesicles #EVresearch #EnvironmentalEVs #EVbiology #Biotech #AquaticScience

We recently had the opportunity to share Acytronix’s vision for “Diagnostics in a Vesicle” at the ETH Deeptech Summit. Our CEO, Dr. Vadim Krivitsky, spoke about how extracellular vesicle (EV) purification plays a key role in the future of personalized medicine, and what it takes to move this technology from the lab to real-world impact. PMED, our portable device for fast and efficient extracellular vesicle isolation, enables high-purity EV preparation at scale (100 samples per day), improving sensitivity and selectivity for liquid biopsy applications, including disease- and tissue-specific marker analysis and immunoaffinity-based EV subpopulation purification. Vadim also highlighted key milestones along our journey, from commercialization and deployment of over 1,000 units to ongoing projects advancing liquid biopsy and EV-based diagnostics. Curious to learn more? We’d love to connect. #ExtracellularVesicles #LiquidBiopsy #ETHDeeptechSummit #PersonalizedMedicine ETH Entrepreneurship

🎉 Excited to share the latest publication in 𝘋𝘳𝘶𝘨 𝘋𝘦𝘭𝘪𝘷𝘦𝘳𝘺 𝘢𝘯𝘥 𝘛𝘳𝘢𝘯𝘴𝘭𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩! 𝐈𝐬𝐨𝐥𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐛𝐚𝐜𝐭𝐞𝐫𝐢𝐚𝐥 𝐞𝐱𝐭𝐫𝐚𝐜𝐞𝐥𝐥𝐮𝐥𝐚𝐫 𝐯𝐞𝐬𝐢𝐜𝐥𝐞𝐬 𝐟𝐫𝐨𝐦 𝐫𝐚𝐰 𝐬𝐚𝐦𝐩𝐥𝐞𝐬 𝐮𝐬𝐢𝐧𝐠 𝐚 𝐩𝐨𝐫𝐭𝐚𝐛𝐥𝐞 𝐦𝐢𝐜𝐫𝐨𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞𝐝 𝐞𝐥𝐞𝐜𝐭𝐫𝐨𝐜𝐡𝐞𝐦𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞 This paper presents a novel portable electrochemical platform enabling rapid, selective, and contamination-reduced isolation of bacterial extracellular vesicles (EVs) directly from raw biological samples. Compared to conventional methods like ultracentrifugation, our #PMED delivers unmatched purity, reduced contaminants, and superior selectivity, as confirmed by advanced characterization techniques. This approach offers a promising step toward 𝘱𝘰𝘪𝘯𝘵-𝘰𝘧-𝘤𝘢𝘳𝘦 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤𝘴 (e.g., urinary tract infections) and advances research on 𝘮𝘪𝘤𝘳𝘰𝘣𝘪𝘢𝘭 𝘤𝘰𝘮𝘮𝘶𝘯𝘪𝘤𝘢𝘵𝘪𝘰𝘯 and 𝘪𝘮𝘮𝘶𝘯𝘦 𝘮𝘰𝘥𝘶𝘭𝘢𝘵𝘪𝘰𝘯. Congratulations on the publication: Valeria Mantella, Siiri Bienz, Finn Brigger, Edouard Baulier, Marie Ramus, Nicole Zoratto, Steffen Honrath, Naresh Kumar, Sibilla Sander, Jörn Dengjel, Renato Zenobi, Vadim Krivitsky & Jean-Christophe Leroux. 🔗 https://lnkd.in/eAZDhZku #ExtracellularVesicles #DrugDelivery #Diagnostics #PointOfCare #BacterialEVs #TranslationalResearch #EVs #Bacterial #Immunomodulation #GramPositive #GramNegative #Microbiology

We are happy to share an exciting update! Our biological nanoparticle purification system is now installed and operational at the Weizmann Institute of Science, recently ranked among the world's leading research institutions for research quality. We had the pleasure of demonstrating our technology to Dr. Avraham Dayan, Head of Unit, and his team. We are proud that the Acytronix platform is now available to researchers as part of the Weizmann Institute's Multidisciplinary Vesicle Program (https://lnkd.in/eh-HK2N3). The Acytronix platform enables rapid, high-yield, and highly specific extracellular vesicle (EV) isolation through immunoaffinity capture and selective electrochemical release. All of this is delivered through a simple handheld device that fits comfortably in one hand, making advanced EV purification more accessible and efficient. It was a privilege to visit the institute, showcase our technology, and learn more about the groundbreaking research being conducted within the Multidisciplinary Vesicle Program. with Vadim Krivitsky #WeizmannInstituteOfScience #ExtracellularVesicles #EVResearch #BiotechInnovation #LifeScience #Nanomedicine #Acytronix #ResearchExcellence

Last week, Acytronix had the pleasure of participating in the Multidisciplinary Vesicle Program webinar and live demonstration event hosted at the Weizmann Institute of Science. The event featured a seminar and live demonstration showcasing our Ultrafast Electro-Immunopurification technology for biological nanoparticles. Our CEO, Dr. Vadim Krivitsky, delivered the presentation and led the hands-on demonstration, during which extracellular vesicles (EVs) were purified from three raw biological samples provided by different research groups, followed by Nanoparticle Tracking Analysis (NTA) characterization. For example, the purification of EVs from a 0.5 mL plasma sample, yielding ~2×10¹¹ EVs/mL (measured by Particle Metrix GmbH NTA platform, see the attached image from the demonstration). The session highlighted the speed, efficiency, and robustness of the workflow while fostering valuable scientific discussions among the participating teams. We would like to thank Dr. Avraham Dayan for his excellent organization and warm hospitality, as well as all participating groups for their collaboration, insightful questions, and contribution of samples. We look forward to continuing these conversations and reconnecting with the community at the upcoming EVTech 2026 Conference. #ExtracellularVesicles #EVs #Nanoparticles #Biotechnology #LifeSciences #EVResearch #Innovation #Acytronix

🌟 Excited to share that our CEO, Dr. Vadim Krivitsky, recently visited VIB Tech Watch in Belgium, where he presented Acytronix’s EVs-purification technology to leading researchers. Vadim demonstrated the parallel isolation of multiple clinical plasma samples using our compact, portable electronic releasing unit and PMED cartridges, all of which fit easily into a backpack. The entire process was completed in less than one hour. This is the breakthrough the field has been waiting for: - No sample preprocessing - No centrifugation - No cleaning steps - No pre-separation Simply insert the device directly into the raw clinical sample and selectively capture the biological particles of interest. A big thank you to the VIB Tech Watch team, especially Sarah Geurs, Toon Swings and Andries De Koker, for the kind invitation and for organizing this insightful demonstration. If you’re working with extracellular vesicles, liquid biopsy, or biomarker research and would like to learn more about our rapid, portable EV isolation technology, feel free to reach out. 🔗 Learn more: https://acytronix.ch/ Wai Long Tam VIB Technologies VIB VIB-UGent #Biotechnology #ExtracellularVesicles #EVIsolation #LiquidBiopsy #MedicalBiotechnology #Exosomes

Happy to share an exciting update! Our biological nanoparticle purification system is now available at the Center for Extracellular Vesicle Research (EVR) (https://evr.unibe.ch/) at the University of Bern, one of Switzerland’s leading universities. The Acytronix platform enables rapid, high-yield, and highly specific extracellular vesicle (EV) isolation, as well as fast modification, loading, and labeling of EVs through immunoaffinity capture and selective electrochemical release. All of this is delivered in a simple handheld device that fits comfortably in one hand. This makes advanced EV purification and engineering more accessible and efficient. It was a privilege to visit the Center, showcase our technology, and learn more about the groundbreaking research being conducted there. Thank you to Cristina Zivko, and Ali Hashemi Gheinani for the warm welcome and insightful discussions. with Vadim Krivitsky #ExtracellularVesicles #EVs #Nanoparticles #Biotechnology #LifeSciences #EVResearch #Innovation #Acytronix

We were happy to host Prof. Carlo Tremolada, MD, Founder and Chairman of Exogems SA, a Swiss biotech company dedicated to unlocking the therapeutic potential of exosomes, at the Acytronix laboratory. Prof. Tremolada is a world-renowned reconstructive surgeon, researcher, and pioneer in regenerative medicine. During his visit, we explored how two promising technologies could be combined into a streamlined regenerative therapy workflow: lipofat harvesting and processing using Prof. Tremolada's FDA-cleared Lipogems® device, followed by extracellular vesicle (EV) purification using Acytronix's platform, which was identified as the most suitable EV purification method for integration into this workflow. We look forward to sharing the scientific findings from this work in an upcoming manuscript. This integrated approach has the potential to enable the development of autologous regenerative therapies directly within the operating room. with Vadim Krivitsky #RegenerativeMedicine #Lipogems #Exosomes #ExtracellularVesicles #Biotech #Innovation #OperatingRoom

We are pleased to share that our platform is currently being evaluated by NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) for nureo- regenerative application. NurExone Biologic Inc is a leader in the field of exosome-based therapeutics and has developed ExoTherapy, a cutting-edge exosome-based drug delivery platform. The company is also advancing its lead product, ExoPTEN, as a novel therapy for acute spinal cord injuries, aiming to transform outcomes in neuroregeneration and repair. We are proud to see our platform contributing to the exploration of next-generation regenerative medicine solutions, enabling efficient and rapid extracellular vesicle separation for advanced research and therapeutic development. With Lior Shaltiel, PhD and Danil Kazeev.